Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. (Q47616090)

4 February 2018

title

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. (English)

1 reference

4 February 2018

7

Claes G Trope

1 reference

4 February 2018

author name string

Ben Davidson

1

1 reference

4 February 2018

Emilyn Alejandro

2

1 reference

4 February 2018

Vivi Ann Flørenes

3

1 reference

4 February 2018

Jeanne-Mette Goderstad

4

1 reference

4 February 2018

Björn Risberg

5

1 reference

4 February 2018

Gunnar B Kristensen

6

1 reference

4 February 2018

Elise C Kohn

8

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

4 February 2018

published in

Cancer

1 reference

4 February 2018

volume

100

1 reference

4 February 2018

issue

10

1 reference

4 February 2018

page(s)

2139-2147

1 reference

4 February 2018

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Structure and chromosomal location of the human granulin gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Granulins, a novel class of peptide from leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Cellular localization of gene expression for progranulin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer--a multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Progranulin is a mediator of the wound response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20219

7 January 2021

Identifiers

DOI

10.1002/CNCR.20219

1 reference

4 February 2018

PubMed ID

15139056

1 reference

4 February 2018